StockWatch
·

AKSHARCHEM (INDIA) LTD.-$

BSE: 524598

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
160.52
+13.9%+79.7%
Expenditure
146.43
+17.2%+58.4%
Net Profit
13.32
-12.4%+1073.1%
OPM %
13.07%
-2.99pp+8.54pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-24.4326.7677.95129.14180.33Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

AksharChem swings to ₹13.3 Cr standalone profit in Q2 FY27 as revenue surges 80% YoY

specialty chemicals · dye intermediates · earnings turnaround

ResultsQ2 FY2719 Oct 20263 minMetals & Mining
Latest
Board Meeting19 Oct, 5:40 pm

AksharChem swings to ₹13.3 Cr standalone profit in Q2 FY27 as revenue surges 80% YoY

AksharChem (India) reported standalone revenue from operations of ₹160.48 Cr for Q2 FY27 (quarter ended September 30, 2026), up 79.7% YoY from ₹89.30 Cr a year ago and up 13.9% QoQ from ₹140.87 Cr in Q1 FY27. Standalone PAT came in at ₹13.32 Cr, reversing a ₹1.37 Cr net loss in Q2 FY26 — a clear YoY turnaround. That year-ago comparison is itself flattered: Q2 FY26 carried a ₹1.70 Cr insurance-claim exceptional gain (final settlement of a May 2024 fire-damage claim at the company's VS Plant), so the underlying year-ago loss was closer to ₹3.07 Cr — making the swing to this quarter's profit sharper on a like-for-like basis. The current quarter carried no exceptional items. Net profit margin was 8.3% this quarter, down from 10.8% in Q1 FY27 but up sharply from -1.5% a year ago. PAT also slipped 12.4% QoQ (₹13.32 Cr vs ₹15.21 Cr) even as revenue grew: operating profit (PBT before exceptional items, with finance cost and depreciation added back) eased to ₹21.01 Cr (13.1% of revenue) from ₹22.65 Cr (16.1%) in Q1 FY27. The main swing factor was the "changes in inventories" line, which moved from a ₹20.97 Cr credit in Q1 FY27 (inventory build) to a ₹10.33 Cr charge in Q2 FY27 (inventory drawdown) — a roughly ₹31 Cr adverse swing that outpaced the ₹19.6 Cr QoQ revenue gain, even though raw-material cost as a share of revenue actually eased to 52.6% from 60.0% in Q1. There is no analyst/street coverage of this small-cap stock (Tipranks and Simply Wall St show no consensus EPS estimates), so a vs-street read isn't possible, and the company has issued no formal forward guidance in its filings or press commentary. The filing itself carries no separate management commentary beyond standard notes confirming the single-segment "Chemical Business" classification and reiterating the fire-claim history. H1 FY27 cumulative PAT of ₹28.53 Cr has already reversed both the ₹0.66 Cr H1 FY26 loss and the ₹0.44 Cr full-year FY26 net loss the company posted in March 2026. The same board meeting also approved re-designating and re-appointing Munjal M. Jaykrishna as Managing Director & CEO and renewed Sachin M. Jaykrishna's term as Whole-Time Director, both for three years — a governance-continuity move alongside the results, with no direct bearing on the reported numbers.

19 Oct 2026, 05:40 pm

Corporate Events

Board MeetingAKSHARCHEM
2026
19Oct

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingAKSHARCHEM
2026
22Sep

Board Meeting

The 37th Annual General Meeting of the Company is scheduled …

BSE Filing ↗
DividendAKSHARCHEM
2026
15Sep

₹0.5 / share

BSE Filing ↗
Board MeetingAKSHARCHEM
2026
12Aug

Board Meeting

The Board of Directors meeting is scheduled to consider, app…

BSE Filing ↗
Board MeetingAKSHARCHEM
2026
21May

Board Meeting

The Board of Directors of the Company at its meeting held on…

BSE Filing ↗
DividendAKSHARCHEM
2025
5Sep

₹0.75 / share

BSE Filing ↗
Board MeetingAKSHARCHEM
2024
12Nov

Board Meeting

consider, approve and take on record Unaudited Financial Res…

BSE Filing ↗
Board MeetingAKSHARCHEM
2024
29May

Board Meeting

consider, approve and take on record the Audited Financial R…

BSE Filing ↗
Board MeetingAKSHARCHEM
2024
30Jan

Board Meeting

Consider, approve and take on record the Unaudited Financial…

BSE Filing ↗
Board MeetingAKSHARCHEM
2023
7Nov

Board Meeting

Consider and approve Unaudited Financial Results for quarter…

BSE Filing ↗
Board MeetingAKSHARCHEM
2023
10Aug

Board Meeting

Consider and approve and take on record Unaudited Financial …

BSE Filing ↗